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Leishmaniasis is a worldwide parasitic disease, caused by monoflagellate parasites of the genus Leishmania. In the search for more
effective agents against these parasites, the identification of molecular targets has been attempted to ensure the efficiency of drugs
and to avoid collateral damages on the host’s cells. In this work, we have investigated some of the mechanisms of action of a group
of natural sesquiterpene lactones that are effective against Leishmania mexicana mexicana promastigotes. We first observed that
the antiproliferative effect of mexicanin I (Mxc), dehydroleucodine (DhL), psilostachyin (Psi), and, at lesser extent, psilostachyin
C (Psi C) is blocked by 1.5mM reduced glutathione. The reducing agent was also able to reverse the early effect of the compounds,
suggesting that lactonesmay react with intracellular sulfhydryl groups.Moreover, we have shown that all the sesquiterpene lactones,
except Psi C, significantly decreased the endogenous concentration of glutathione within the parasite. Consistent with these
findings, the active sesquiterpene lactones increased between 2.7 and 5.4 times the generation of ROS by parasites. These results
indicate that the induction of oxidative stress is at least one of the mechanisms of action of DhL, Mxc, and Psi on parasites while
Psi C would act by another mechanism.
1. Introduction
Leishmaniasis is a parasitic disease caused by flagellated
parasites of the genus Leishmania and transmitted by phle-
botomine sandflies. These parasites exhibit a heteroxenous
life cycle, alternating between intracellular amastigotes in the
mammalian cells and flagellate promastigotes in the vector.
Leishmaniasis affects about 12 million people worldwide
and, according to the World Health Organization (WHO),
2 million of new cases occur annually and 350 million
people are considered at risk of contracting leishmaniasis [1].
The clinical forms of the disease depend on the species of
Leishmania involved and include local infections of the skin,
subcutaneous tissue, and regional lymphatic nodes (cuta-
neous leishmaniasis); metastatic infections of the oronasal
mucosa (mucocutaneous leishmaniasis); and disseminated
infection involving visceral organs (visceral leishmaniasis)
[2].
Leishmaniasis is distributed worldwide with foci of infec-
tion in Central and South America, Southern Europe, North
and East Africa, the Middle East and India [3]. In Argentina,
this parasitosis affects the northern region of the countrywith
an incidence that has increased over the last two decades [4].
Current drugs used to treat leishmaniasis include pen-
tavalent antimonials, pentamidine, and amphotericin B,
which induce serious toxic effects on patients. Parasite
resistance to these drugs has also been described. New
formulations, such as liposomal amphotericin B and other
drugs (miltefosine, paromomycin), have serious drawbacks
such as parenteral route of administration, duration of the
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Figure 1: Chemical structures of the sesquiterpene lactone: mexicanin I (a), dehydroleucodine (b), psilostachyin (c), and psilostachyin C (d).
treatment, teratogenic effects, toxicity, and cost of treatment,
which limit their use in endemic areas [5]. Therefore, there
is an urgent need for novel candidates to treat this parasitic
disease.
Sesquiterpene lactones, a group of natural compounds
characteristic of the Asteraceae family, have been pointed out
as good candidates for antiprotozoal therapy since many of
them are active against trypanosomatids [6–8]. Moreover, we
have previously described the trypanocidal and leishmanici-
dal activity of natural sesquiterpene lactones isolated from
Argentinean Asteraceae species [9–16].
One of the most important aspects in antiprotozoal
drug discovery is to determine the mechanism of action
of the potential candidates and to identify the possible
molecular targets upon which these compounds act. Among
othermechanisms, it is presumed that sesquiterpene lactones
could exert their leishmanicidal activity by the generation
of an oxidative environment within the parasite [17, 18].
The particular defense mechanism against oxidative stress in
trypanosomatids makes parasites susceptible to these kinds
of compounds.
In this sense, the aim of the present work was to evaluate
the possible effect of four bioactive sesquiterpene lactones:
dehydroleucodine (DhL); mexicanin I (Mxc). psilostachyin
(Psi), and psilostachyin C (Psi C) on the defense mechanism
of Leishmania mexicana mexicana against oxidative stress.
2. Materials and Methods
2.1. Compounds. Mexicanin I (Mxc) was isolated from
the aerial parts of Gaillardia megapotamica and dehydro-
leucodine (DhL) was isolated from Artemisia douglasiana
as previously described [19]. Psilostachyin (Psi) and
psilostachyin C (PsiC) have been isolated from Ambrosia
tenuifolia and A. scabra, respectively [11, 13].
2.2. Parasites. Axenic cultures of Leishmania mexicanamexi-
cana promastigotes were grown in Diamond’s liquid medium
(0.106M NaCl, 29mM KH
2
PO
4
, 23mM K
2
HPO
4
, 12.5 g/L
tryptone, 12.5 g/L tryptose, and 12.5 g/L yeast extract, adjusted
to pH 7.2) supplemented with 75𝜇M hemine, 75 IU/mL
penicillin, 75 𝜇g/mL streptomycin, and 20% fetal bovine
serum at 25∘C.
2.3. Treatments. Leishmania mexicana mexicana promastig-
otes (2 × 106 parasites) were incubated with 0.5𝜇g/mL of
Mxc, Psi, or Psi C or 2.5 𝜇g/mL of DhL, at 25∘C, either
in the presence or in the absence of 1.5mM glutathione
(GSH). The concentrations used for each compound were
those corresponding to each IC
50
, as previously determined
(data not shown). Aliquots of the parasites were collected
every 24 h and counted in a Neubauer hemocytometer [16].
In other experiments, parasites were preincubated with the
compounds for 30min and the reducing agent was then
added. Alternatively, the lactones were withdrawn after incu-
bation for 1 h and before adding GSH. Controls were carried
out in the presence of DMSO (less than 0.05%) which was
used to dissolve the compounds.
2.4.Measurement of ROS. Thefluorescent probe,H
2
DCFDA,
was used to measure the intracellular generation of ROS,
according to Duranteau et al. [20]. Briefly, parasites (1 ×
106 cells) were previously treated with the lactones (10 𝜇g/mL
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Figure 2:The effect of sesquiterpene lactones on the growth of L. mexicana mexicana is blocked by adding of GSH. Parasites were incubated
with the lactones; dehydroleucodine (DhL) (a), mexicanin I (Mxc) (b), psilostachyin (Psi) (c), or psilostachyin C (Psi C) (d) in the presence
or in the absence of 1.5mM glutathione (GSH), as indicated in the figure. Parasite counts were done daily. Glutathione alone did not affect
the parasite growth (a).
of each sesquiterpene lactone for 3 h) and then incubated
with 10 𝜇M of the probe for 1 h at room temperature in the
dark. The fluorescence intensity of H
2
DCFDA was measured
at 507 nm excitation and 538 nm emission wavelengths. To
validate the assay, generation of ROS by 4mMH
2
O
2
was used
as a positive control.
2.5. Measurement of Reduced Glutathione. Endogenous GSH
was measured in parasite lysates by using 5,5󸀠-dithiobis-2-
nitrobenzoic acid (DTNB), according to Beutler et al. [21].
Briefly, parasites (1 × 107 cells/mL) were previously incubated
with the lactones (10 𝜇g/mL) for 3 h at 25∘C then pelleted,
lysed with 200𝜇L lysis solution (10% EDTA, 0.5% Triton X-
100 in bidistilled water) during 30min, and centrifuged at
12,000×g. Supernatants weremixedwith 300𝜇L of solution P
(0.2MHPO
3
, 5mM EDTA, and 5.1MNaCl) and centrifuged
again at 12,000×g. Supernatants were mixed with 800𝜇L of
0.3MNa
2
HPO
4
, and 200𝜇L of DTNB (in 1% sodium citrate).
Absorbances were then measured in a spectrophotometer at
412 nm, and the concentration of GSH was derived from a
standard curve.
2.6. Statistical Analysis. Results are presented as mean ± SD.
The level of statistical significance was determined by using
one-way analysis of variance (ANOVA) followed byDunnett’s
multiple comparisons test.
3. Results and Discussion
We had previously reported the antileishmanial activity of
Mxc, DhL, Psi, and Psi C (Figure 1) [9–16]. The common
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Figure 3: The effect of glutathione (GSH) on the number of parasites preincubated with 0.5 𝜇g/mL mexicanin I (Mxc), psilostachyin (Psi)
or psilostachyin C (Psi C) or with 2.5𝜇g/mL of dehydroleucodine (DhL), for 30min (a) or preincubated 1 h with the lactones and followed
by withdrawal of the compounds before adding the reducing agent (b). Bars represent the means of parasite concentration ± SD from three
independent experiments. (∗∗) and (∗) indicate significant differences with the control (𝑃 < 0.01 and 𝑃 < 0.05 resp.).
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Figure 4: Concentration of endogenous glutathione in the parasites
after treatment with 10𝜇g/mL dehydroleucodine (DhL), mexicanin
I (Mxc), psilostachyin (Psi), or psilostachyin C (Psi C), as described
in materials and methods. (∗ ∗ ∗): significant differences with the
control (𝑃 < 0.02). H
2
O
2
(5mM) was used as positive control.
functional group 𝛼-methylene-𝛾-lactone present in the
sesquiterpene lactones is believed to be responsible for their
antiprotozoal activity. However, the presence of other alky-
lating groups such as 𝛼,𝛽-unsaturated cyclopentenones and
other factors, such as lipophilicity, molecular geometry, and
chemical environment, may also influence their bioactivity
[22].
In this work we have corroborated the antiprolifera-
tive effect of the four lactones on L. mexicana mexicana
promastigotes and we have demonstrated that this effect
was blocked by 1.5mM GSH (Figure 2). As these lactones
are nonpolar molecules they could easily pass through the
parasite’s plasmalemma.The blocking effect of GSHmight be
due to the transformation of the compounds into derivatives
unable to traverse the plasmalemma. However, it is more
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Figure 5: Generation of ROS by the parasites after treatment
with 10𝜇g/mL of mexicanin I (Mxc), dehydroleucodine (DhL),
psilostachyin (Psi), and psilostachyin C (Psi C). Values are expressed
as units of fluorescence emitted by the probe at 538 nm. Bars
represent the means of fluorescence ± SD from three independent
experiments. (∗): significant differences with the control (𝑃 < 0.05).
likely that the compounds interferewith the intracellular con-
centration of GSH, as the antiproliferative effect of lactones
can be reversed by GSH when the reducing agent is added
30min after incubation with the compounds or 1 h after
incubation followed by withdrawal of the lactones (Figure 3).
In addition, it was observed that DhL, Mxc, and Psi, but
not Psi C, reduced the concentration of endogenous GSH
(Figure 4).
On the other hand, treatment with DhL, Mxc, or Psi,
but not Psi C, induced a significant increase of ROS in L.
mexicana promastigotes (Figure 5).
The generation of free radicals in Leishmania by the
sesquiterpene lactones would be deleterious for trypanoso-
matids, as the regulation of oxidative stress is crucial for
parasite survival. It is known that sesquiterpene lactones
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react with sulfhydryl groups by the Michael-type addition
and therefore could act by inhibiting the activity of enzymes
that are vital against oxidative stress (e.g., trypanothione
reductase) [17].This situation could lead to an increase in the
level of reactive oxygen species and to parasite damage via the
generation of an oxidative burst by a deregulation of the redox
balancewithin the parasite [23]. However, a direct interaction
of the compounds with GSH or trypanothione should not be
ruled out.
The decrease in the concentration of glutathione within
the parasites induced by the sesquiterpene lactones Mxc,
DhL, and Psi would lead to an enhancement in the produc-
tion of reactive oxygen species. These results are in accor-
dance with ROS production and the in vitro leishmanicidal
activity, with psilostachyin C being the less active compound
against L. mexicana. Given that sesquiterpene lactones can
also induce GSH depletion and ROS generation in certain
mammalian cells (e.g., tumor cells) [24], these compounds
should be improved before use as therapeutic agents against
Leishmania.
One vital step in the process of drug development is the
identification of the molecular target/s of such drugs. Taking
into consideration the data obtained, we can suggest that
Mxc, DhL, and Psi were able to affect the defense mechanism
against oxidative stress in L.mexicana.Thismechanism could
be related to inhibition of key enzymes that maintain redox
balance in the parasite.
This study must be complemented by further investiga-
tions on amastigotes forms of Leishmania and on in vivo
models of leishmaniasis.
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